Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 16;14(10):1945.
doi: 10.3390/genes14101945.

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia

Malcolm Forbes  1   2 , Mal Hopwood  2 , Chad A Bousman  2   3
Affiliations

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia

Malcolm Forbes et al. Genes (Basel). .

Abstract

Pharmacogenomic (PGx) testing to inform antidepressant medication selection and dosing is gaining attention from healthcare professionals, patients, and payors in Australia. However, there is often uncertainty regarding which test is most suitable for a particular patient. Here, we identified and evaluated the coverage of CYP2D6 and CYP2C19 variants in commercial antidepressant PGx testing panels in Victoria, a large and ethnically diverse state of Australia. Test characteristics and star alleles tested for both genes were obtained directly from pathology laboratories offering PGx testing and compared against the Association of Molecular Pathology's recommended minimum (Tier 1) and extended (Tier 2) allele sets. Although all tests covered the minimum recommended alleles for CYP2C19, this was not the case for CYP2D6. This study emphasizes that PGx tests might not be suitable for all individuals in Australia due to the limited range of star alleles assessed. Inadequate haplotype coverage may risk misclassification of an individual's predicted metabolizer phenotype, which has ramifications for depression medication selection and dosage. This study underscores the urgent need for greater standardization in PGx testing and emphasizes the importance of considering genetic ancestry when choosing a PGx testing panel to ensure optimal clinical applicability.

Keywords: CYP2C19; CYP2D6; personalized medicine; pharmacogenetics; psychiatry.

PubMed Disclaimer

Conflict of interest statement

M.F. and M.H. have no conflict of interest to declare. C.B. is the founder of Sequence2Script Inc., Calgary, AB, Canada.

References

    1. Bousman C.A., Zierhut H., Müller D.J. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection. Clin. Pharmacol. Ther. 2019;106:309–312. doi: 10.1002/cpt.1432. - DOI - PubMed
    1. Bousman C.A., Stevenson J.M., Ramsey L.B., Sangkuhl K., Hicks J.K., Strawn J.R., Singh A.B., Ruano G., Mueller D.J., Tsermpini E.E., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. Clin. Pharmacol. Ther. 2023;114:51–68. doi: 10.1002/cpt.2903. - DOI - PMC - PubMed
    1. Murphy L.E., Fonseka T.M., Bousman C.A., Muller D.J. Gene-drug pairings for antidepressants and antipsychotics: Level of evidence and clinical application. Mol. Psychiatry. 2022;27:593–605. doi: 10.1038/s41380-021-01340-6. - DOI - PubMed
    1. Hicks J., Sangkuhl K., Swen J., Ellingrod V., Müller D., Shimoda K., Bishop J., Kharasch E., Skaar T., Gaedigk A., et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin. Pharmacol. Ther. 2017;102:37–44. doi: 10.1002/cpt.597. - DOI - PMC - PubMed
    1. Maruf A.A., Fan M., Arnold P.D., Müller D.J., Aitchison K.J., Bousman C.A. Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada. Can. J. Psychiatry. 2020;65:521–530. doi: 10.1177/0706743720904820. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources